Drug Profile
Research programme: sedatives - Minrad International
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Dermatrends; MINRAD International
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Sedation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Sedation in USA (Transdermal)
- 03 Apr 2007 Preclinical trials in Sedation in USA (Transdermal)